Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $74,650 | $2,362,160 | $23,925,768 | $1,613,965,293 |
| - Cash | $98,776 | $24,948 | $120,229 | $178,660 |
| + Debt | $8,119 | $9,813 | $760 | $956 |
| Enterprise Value | -$16,007 | $2,347,025 | $23,806,299 | $1,613,787,589 |
| Revenue | $10,094 | $7,768 | $0 | $0 |
| % Growth | 29.9% | – | – | – |
| Gross Profit | $2,329 | $3,027 | $0 | $0 |
| % Margin | 23.1% | 39% | – | – |
| EBITDA | -$74,323 | -$114,089 | -$110,838 | -$92,262 |
| % Margin | -736.3% | -1,468.7% | – | – |
| Net Income | -$130,036 | -$116,658 | -$110,218 | -$92,287 |
| % Margin | -1,288.3% | -1,501.8% | – | – |
| EPS Diluted | -176.6 | -6,368.84 | -811.68 | -163,968 |
| % Growth | 97.2% | -684.6% | 99.5% | – |
| Operating Cash Flow | -$60,925 | -$102,003 | -$98,053 | -$75,557 |
| Capital Expenditures | -$120 | -$7,895 | -$48,147 | -$35,307 |
| Free Cash Flow | -$61,045 | -$109,898 | -$146,200 | -$110,864 |